Cargando…

Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is characterized by intra-hepatic fat accumulation and mechanisms involved in its pathogenesis are not fully explained. Lysosomal Acid Lipase (LAL) is a key enzyme in lipid metabolism. We investigated its activity in patients with fatty liver. LAL activity (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baratta, Francesco, Pastori, Daniele, Del Ben, Maria, Polimeni, Licia, Labbadia, Giancarlo, Di Santo, Serena, Piemonte, Fiorella, Tozzi, Giulia, Violi, Francesco, Angelico, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534687/ https://www.ncbi.nlm.nih.gov/pubmed/26288848 http://dx.doi.org/10.1016/j.ebiom.2015.05.018

Ejemplares similares

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?
por: Baratta, Francesco, et al.
Publicado: (2015)

Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
por: Baratta, Francesco, et al.
Publicado: (2019)

PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress
por: Carpino, Guido, et al.
Publicado: (2017)

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis
por: Pastori, Daniele, et al.
Publicado: (2015)

Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease
por: Ferri, Flaminia, et al.
Publicado: (2020)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
por: Del Ben, Maria, et al.
Publicado: (2018)

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease
por: Del Ben, Maria, et al.
Publicado: (2014)

Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review
por: Coronati, Mattia, et al.
Publicado: (2022)

Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide Are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2020)

New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
por: Ferro, Domenico, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study
por: Pastori, Daniele, et al.
Publicado: (2021)

Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2022)

Moderate Weight Loss Decreases Oxidative Stress and Increases Antioxidant Status in Patients with Metabolic Syndrome
por: Del Ben, Maria, et al.
Publicado: (2012)

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
por: Di Costanzo, Alessia, et al.
Publicado: (2018)

Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis
por: Pastori, Daniele, et al.
Publicado: (2021)

Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment
por: Del Ben, Maria, et al.
Publicado: (2012)

Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver
por: Carotti, Simone, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and the Kidney: A Review
por: Umbro, Ilaria, et al.
Publicado: (2021)

Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver
por: Del Ben, M., et al.
Publicado: (2014)

Sex-Related Differences in the Association between Metabolic Syndrome and Gallstone Disease
por: Baratta, Francesco, et al.
Publicado: (2021)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study
por: Baratta, Francesco, et al.
Publicado: (2021)

A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease
por: Tovoli, Francesco, et al.
Publicado: (2017)

HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Di Costanzo, Alessia, et al.
Publicado: (2020)

High Compliance to Mediterranean Diet Associates with Lower Platelet Activation and Liver Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2022)

Challenges in Improving Adherence to Diet and Drug Treatment in Hypercholesterolemia Patients
por: Baratta, Francesco, et al.
Publicado: (2023)

Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
por: Basili, Stefania, et al.
Publicado: (2018)

SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020)

Thrombosis in pre- and post-vaccination phase of COVID-19
por: Violi, Francesco, et al.
Publicado: (2021)

Is the Mediterranean Diet the Best Approach to NAFLD Treatment Today?
por: Angelico, Francesco, et al.
Publicado: (2021)

Lipases in lysosomes, what for?
por: Czaja, Mark J., et al.
Publicado: (2009)

Association between non-alcoholic fatty liver disease and obstructive sleep apnea
por: Umbro, Ilaria, et al.
Publicado: (2020)

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review
por: Violi, Francesco, et al.
Publicado: (2016)

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
por: Violi, Francesco, et al.
Publicado: (2016)

Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2012)

Lysosomal acid lipase in cancer
por: Yan, Cong, et al.
Publicado: (2015)

Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach
por: Pastori, Daniele, et al.
Publicado: (2019)

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
por: Pastori, Daniele, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ngu9scl5s40jlt6f8r0km3gii